JPH0791260B2 - Guanidine derivative and its salt - Google Patents

Guanidine derivative and its salt

Info

Publication number
JPH0791260B2
JPH0791260B2 JP31299586A JP31299586A JPH0791260B2 JP H0791260 B2 JPH0791260 B2 JP H0791260B2 JP 31299586 A JP31299586 A JP 31299586A JP 31299586 A JP31299586 A JP 31299586A JP H0791260 B2 JPH0791260 B2 JP H0791260B2
Authority
JP
Japan
Prior art keywords
compound
group
formula
solution
cyclohexyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP31299586A
Other languages
Japanese (ja)
Other versions
JPS63166855A (en
Inventor
等 山口
Original Assignee
第一製薬株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 第一製薬株式会社 filed Critical 第一製薬株式会社
Priority to JP31299586A priority Critical patent/JPH0791260B2/en
Publication of JPS63166855A publication Critical patent/JPS63166855A/en
Publication of JPH0791260B2 publication Critical patent/JPH0791260B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は式(I) [式中、Z1及びZ2はそれそれ独立に=CH−又は=N−
を、R1は水素原子又は式−Q−R5(式中、Qは単結合又
はアルキレン基を、R5は低級アルキル基が置換してもよ
い環状アルキル基を意味する。)で示される基、アルコ
キシカルボニル基、カルボキシル基、ヒドロキシアルキ
ル基またはアルキル基を、R2は水素原子、アルコキシカ
ルボニル基又はカルボキシル基を意味し、該R2はR1と一
緒になってアルキレン基を形成してもよく、R3及びR4
それぞれ独立に水素原子、ハロゲン原子、アルキル基、
アルコキシ基、カルボキシル基、シアノ基又は式 (式中、R6及びR7はそれぞれ独立に水素原子又はアルキ
ル基を意味する。)で示される基を意味する。但し、R1
及びR2が水素原子、Zが=CH−でR3及びR4が水素原子で
ある組合せを除く。]で示される化合物及びその塩に関
する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial field of application] The present invention provides compounds of formula (I) [Wherein Z 1 and Z 2 are independently = CH- or = N-
R 1 is a hydrogen atom or a formula —Q—R 5 (wherein Q represents a single bond or an alkylene group, and R 5 represents a cyclic alkyl group which may be substituted with a lower alkyl group). A group, an alkoxycarbonyl group, a carboxyl group, a hydroxyalkyl group or an alkyl group, R 2 means a hydrogen atom, an alkoxycarbonyl group or a carboxyl group, and R 2 together with R 1 forms an alkylene group. Also, R 3 and R 4 are each independently a hydrogen atom, a halogen atom, an alkyl group,
Alkoxy group, carboxyl group, cyano group or formula (In the formula, R 6 and R 7 each independently represent a hydrogen atom or an alkyl group.). However, R 1
And R 2 is a hydrogen atom, Z is ═CH—, and R 3 and R 4 are hydrogen atoms. ] The compound and its salt shown by these.

式(I)の化合物は強力な抗凝固作用を有し、医薬とし
て有用である。
The compound of formula (I) has a strong anticoagulant effect and is useful as a medicine.

[従来の技術] 従来の抗凝固薬としてはヘパリンやワーファリンが知ら
れている。又、抗凝固作用を示す化合物としてアルギニ
ン誘導体、アミジン誘導体が知られている。
[Prior Art] Heparin and warfarin are known as conventional anticoagulants. Moreover, arginine derivatives and amidine derivatives are known as compounds having an anticoagulant effect.

[発明が解決しようとする問題点] 本発明者は、抗凝固作用を示す新規化合物について鋭意
検討した結果、本発明を完成した。
[Problems to be Solved by the Invention] The present inventors have completed the present invention as a result of extensive studies on novel compounds having an anticoagulant effect.

[発明の構成] 本発明は式(I)の化合物及びその塩に関する。The present invention relates to compounds of formula (I) and salts thereof.

式(I)においてアルキル基としては、メチル、エチ
ル、プロピル、イソプロピル、ブチル、第三級ブチル、
ペンチル、ヘキシル、ヘプチル、デシル等の直鎖状又は
分枝状のものをあげることができる。アルコキシ基とし
てはメトキシ、エトキシ、プロポキシ、ブトキシ、ペン
チルオキシ、ヘキシルオキシ、デシルオキシ等の直鎖状
又は分枝状のものをあげることができる。アルキレン基
としてはメチレン、エチレン、プロピレン、ブチレン、
ペンチレン、ヘキシレン、ヘプチレン等の直鎖状又は分
枝状のものをあげることができる。環状アルキル基とし
てはシクロプロピル、シクロブチル、シクロペンチル、
シクロヘキシル、シクロヘプチル等をあげることができ
る。
Examples of the alkyl group in the formula (I) include methyl, ethyl, propyl, isopropyl, butyl, tertiary butyl,
Examples thereof include linear or branched ones such as pentyl, hexyl, heptyl and decyl. Examples of the alkoxy group include linear or branched ones such as methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, decyloxy and the like. As the alkylene group, methylene, ethylene, propylene, butylene,
Examples thereof include linear or branched ones such as pentylene, hexylene and heptylene. Examples of the cyclic alkyl group include cyclopropyl, cyclobutyl, cyclopentyl,
Cyclohexyl, cycloheptyl, etc. can be mentioned.

式(I)の化合物の塩としては、式(I)のR1,R2,R3
はR4がカルボキシル基である場合それらのカルボキシル
基とナトリウム,カリウム,カルシウム等のアルカリ金
属又はアルカリ土類金属との塩及びアンモニア,エタノ
ールアミン等のアミンとの塩並びにグアニジンの塩酸、
酢酸等の無機酸,有機酸との酸付加塩をあげることがで
きる。
As the salt of the compound of formula (I), when R 1 , R 2 , R 3 or R 4 of formula (I) is a carboxyl group, those carboxyl groups and alkali metals such as sodium, potassium, calcium or alkaline earth Salts with metals and ammonia, amines such as ethanolamine, and guanidine with hydrochloric acid,
Examples thereof include acid addition salts with inorganic acids such as acetic acid and organic acids.

式(I)の化合物は、そのグアニジン部分に以下に示す
ような互変異性体を有し、これらの互変異性体も本発明
化合物の範囲に含まれる。
The compound of formula (I) has tautomers as shown below in its guanidine moiety, and these tautomers are also included in the scope of the compound of the present invention.

又、式(I)の化合物のいくつかは光学異性体を有する
が、これらの光学異性体も本発明化合物の範囲に含まれ
る。
Further, some of the compounds of formula (I) have optical isomers, and these optical isomers are also included in the scope of the compound of the present invention.

式(I)の化合物は種々の方法により製造可能であり、
以下にその代表例を示す。
The compounds of formula (I) can be prepared by various methods,
Typical examples are shown below.

(式中、R1,R2,R3,R4,Z1及びZ2は前記に同じ。) 式(II)の化合物の二塩酸塩を、エタノール等の有機溶
媒中、シアナミドと反応させることにより、式(I)の
化合物を製造することができる。反応は通常約70〜約14
0℃の温度で約5〜約72時間行なわれる。
(In the formula, R 1 , R 2 , R 3 , R 4 , Z 1 and Z 2 are the same as above.) The dihydrochloride of the compound of the formula (II) is reacted with cyanamide in an organic solvent such as ethanol. Thereby, the compound of formula (I) can be produced. The reaction is usually about 70 to about 14
It is carried out at a temperature of 0 ° C. for about 5 to about 72 hours.

(式中、R11は水素原子、−Q−R5、ヒドロキシアルキ
ル基、カルボキシル基又はアルキル基をR21は水素原子
又はカルボキシル基を意味し、該R21はR11と一緒になっ
てアルキレン基を形成してもよく、R31及びR41はそれぞ
れ水素原子、ハロゲン原子、アルキル基、アルコキシ
基、カルボキシル基又は を意味し、Z1,Z2,Q,R5及びR7は前記に同じ。) 式(III)の化合物を希塩酸、希硫酸との鉱酸、もしく
はエタノール等のアルコール系溶媒の存在下塩酸と反応
させることにより式(Ia)の化合物を製造することがで
きる。反応は通常約70〜約150℃の温度で約3〜約72時
間行なわれる。
(In the formula, R 11 represents a hydrogen atom, —Q—R 5 , a hydroxyalkyl group, a carboxyl group or an alkyl group, and R 21 represents a hydrogen atom or a carboxyl group, and R 21 together with R 11 represents an alkylene group. A group may be formed, and R 31 and R 41 are each a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, a carboxyl group or And Z 1 , Z 2 , Q, R 5 and R 7 are the same as defined above. The compound of formula (Ia) can be produced by reacting the compound of formula (III) with hydrochloric acid in the presence of dilute hydrochloric acid, a mineral acid with dilute sulfuric acid, or an alcohol solvent such as ethanol. The reaction is usually performed at a temperature of about 70 to about 150 ° C. for about 3 to about 72 hours.

尚、式(I)において、R1又はR2がカルボキシル基であ
る化合物は、R1又はR2がアルコキシカルボニル基である
式(I)の化合物を希塩酸等の鉱酸と反応させることに
よっても製造することができる。又、式(I)において
R3又はR4がカルボキシル基である化合物はR3又はR4がシ
アノ基である式(I)の化合物を上記と同様に鉱酸と処
理することにより製造することができる。該反応は通常
約80〜約150℃の温度で約1〜約18時間行なわれる。
In the formula (I), the compound in which R 1 or R 2 is a carboxyl group can also be prepared by reacting the compound of the formula (I) in which R 1 or R 2 is an alkoxycarbonyl group with a mineral acid such as dilute hydrochloric acid. It can be manufactured. Also, in formula (I)
The compound in which R 3 or R 4 is a carboxyl group can be produced by treating the compound of the formula (I) in which R 3 or R 4 is a cyano group with a mineral acid in the same manner as above. The reaction is usually performed at a temperature of about 80 to about 150 ° C. for about 1 to about 18 hours.

次に式(II)及び式(III)の原料化合物の製造法につ
いて説明する。
Next, a method for producing the raw material compounds of the formulas (II) and (III) will be described.

(式中、R1,R2,R3,及びR4は前記に同じ。) 式(IV)の化合物を酢酸等のプロトン性溶媒中、発煙硝
酸と反応させることにより、式(V)の化合物とするこ
とができる。これをエタノール等のプロトン性溶媒中又
はこれとジメチルホルムアミド、酢酸エチル等の非極性
溶媒との混合溶媒中白金、パラジウム炭素又はラネーニ
ッケル等の触媒を用いて常圧又は数気圧下接触還元する
ことにより式(IIa)の化合物を製造することができ
る。
(In the formula, R 1 , R 2 , R 3 , and R 4 are the same as above.) The compound of the formula (IV) is reacted with fuming nitric acid in a protic solvent such as acetic acid. It can be a compound. By catalytic reduction of this in a protic solvent such as ethanol or in a mixed solvent thereof with a non-polar solvent such as dimethylformamide and ethyl acetate using a catalyst such as platinum, palladium carbon or Raney nickel under atmospheric pressure or several atmospheres. Compounds of formula (IIa) can be prepared.

(式中、R1,R2,R3,R4及びZ1は前記に同じ。) 式(VI)の化合物を公知の方法(テトラヘドロン21巻24
53頁1965年)に準じて反応させることにより式(VII)
の化合物とすることができる。これを次亜臭素酸ナトリ
ウムと反応させ、次いでエタノール等のプロトン性溶媒
中接触還元することにより式(IIb)の化合物を製造す
ることができる。
(In the formula, R 1 , R 2 , R 3 , R 4 and Z 1 are the same as above.) The compound of the formula (VI) can be prepared by a known method (tetrahedron 21 vol.
P.53 1965) by reacting according to formula (VII)
Can be a compound of The compound of formula (IIb) can be produced by reacting this with sodium hypobromite and then catalytically reducing it in a protic solvent such as ethanol.

(式中、R1,R2,R3,R4,Z1及びZ2は前記に同じ。) 式(VIII)の化合物を上記と同様に反応させることによ
り式(IIc)の化合物を製造することができる。
(In the formula, R 1 , R 2 , R 3 , R 4 , Z 1 and Z 2 are the same as above.) A compound of formula (IIc) is produced by reacting a compound of formula (VIII) in the same manner as above. can do.

又、式(II)の化合物においてR1がヒドロキノアルキル
基である化合物は以下のようにして製造することもでき
る。
Further, the compound of the formula (II) in which R 1 is a hydroquinoalkyl group can also be produced as follows.

(式中、R12はアルコキシカルボニル基又はアルコキシ
カルボニルアルキル基を、R13はヒドロキシアルキル基
を意味し、R2,R3,R4,Z1及びZ2は前記に同じ。) 即ち式(IIc)の化合物をテトラヒドロフラン等の非極
性溶媒中水素化アルミニウムリチウムと反応させること
により式(IIe)の化合物を製造することができる。
(In the formula, R 12 represents an alkoxycarbonyl group or an alkoxycarbonylalkyl group, R 13 represents a hydroxyalkyl group, and R 2 , R 3 , R 4 , Z 1 and Z 2 are the same as above.) A compound of formula (IIe) can be prepared by reacting a compound of IIc) with lithium aluminum hydride in a non-polar solvent such as tetrahydrofuran.

以上のようにして製造された式(II)の化合物をジメチ
ルホルムアミド等の非極性溶媒中N−ベンゾイルシアナ
ミドと反応させることにより式(III)の化合物とする
ことができる。
By reacting the compound of formula (II) produced as described above with N-benzoylcyanamide in a nonpolar solvent such as dimethylformamide, a compound of formula (III) can be obtained.

上記の式(IV),(VI)及び(VIII)の原料化合物は既
知化合物より公知の方法を種々組合わせることにより製
造することができる。
The starting compounds of the above formulas (IV), (VI) and (VIII) can be produced from known compounds by combining various known methods.

[発明の効果] 本発明の式(I)の化合物は、従来の抗凝固薬とは全く
異なる新規の骨格を有し、医薬品として有用な化合物で
ある。以下本発明化合物の有する抗凝固作用を具体的に
示す。
[Effect of the Invention] The compound of formula (I) of the present invention has a novel skeleton completely different from conventional anticoagulants, and is a useful compound as a drug. The anticoagulant effect of the compound of the present invention will be specifically shown below.

抗凝固作用 ヒト血液から、遠心分離機にて血漿を分離させた。その
血漿100μに、検体のトリス緩衝液100μを加え、37
℃で3分間プレインキュベーションした。これに塩化カ
ルシウムの0.02モル溶液100μを加え、クロテック
(三光純薬社製)を用いて、凝固時間を測定した。コン
トロールの凝固時間を二倍に延長する検体の濃度(CT2
と略称する)を求め、これを抗凝固作用の指標とした。
Anticoagulant action Plasma was separated from human blood by a centrifuge. To 100 μl of the plasma, add 100 μl of the sample Tris buffer,
Pre-incubated for 3 minutes at ° C. To this, 100 μ of a 0.02 molar solution of calcium chloride was added, and the coagulation time was measured using Klotech (manufactured by Sanko Junyaku Co., Ltd.). Sample concentration (CT 2) that doubles control clotting time
Is abbreviated) and used as an index of anticoagulant action.

代表的な化合物の抗凝固作用を表1に示す。The anticoagulant activity of representative compounds is shown in Table 1.

表1より明らかなように、本発明の化合物は強力な抗凝
固作用を示した。
As is clear from Table 1, the compounds of the present invention showed a strong anticoagulant action.

以下、本発明を更に実施例により説明するが、本発明は
これらによって限定されるものではない。
Hereinafter, the present invention will be further described with reference to examples, but the present invention is not limited thereto.

実施例1 4,4′−[(シクロヘキシル)メチレン]ビス(フェニ
ルグアニジン)二塩酸塩 (1)4,4′−[(シクロヘキシル)メチレン]ビス
(ニトロベンゼン) 発煙硝酸9ml、酢酸4mlの混酸中に、(シクロヘキシル)
(ジフェニル)メタン2.3gの酢酸5ml溶液を0−5℃で
滴下した。同温度で1時間撹拌後、反応液を氷水中に注
いだ。析出物をベンゼンで抽出した。その抽出液を、飽
和重曹水、水で順次洗浄し芒硝で乾燥後、溶媒を減圧留
去した。残渣をエーテルで粉末化させた後、塩化メチレ
ン−石油エーテルから再結晶し、表記化合物1.6gを得
た。融点173−175℃。
Example 1 4,4 '-[(Cyclohexyl) methylene] bis (phenylguanidine) dihydrochloride (1) 4,4'-[(Cyclohexyl) methylene] bis (nitrobenzene) In a mixed acid of fuming nitric acid 9 ml and acetic acid 4 ml. , (Cyclohexyl)
A solution of 2.3 g of (diphenyl) methane in 5 ml of acetic acid was added dropwise at 0-5 ° C. After stirring at the same temperature for 1 hour, the reaction solution was poured into ice water. The precipitate was extracted with benzene. The extract was washed successively with saturated aqueous sodium hydrogen carbonate and water and dried over sodium sulfate, and the solvent was evaporated under reduced pressure. The residue was triturated with ether and recrystallized from methylene chloride-petroleum ether to give the title compound (1.6 g). Melting point 173-175 [deg.] C.

(2)4,4′−[(シクロヘキシル)メチレン]ジアニ
リン二塩酸塩 (1)で製した化合物1.8g、10%パラジウム炭素0.3g、
N,N−ジメチルホルムアミド2ml、エタノール50mlの混合
物を水素−気圧下、室温で4時間振盪した。触媒濾去
後、濾液を減圧濃縮した。残渣をエタノール30mlに溶解
させた。その溶液に濃塩酸2mlを加え、減圧濃縮した。
析出した結晶を濾取しエーテルで洗浄後、乾燥して表記
化合物2.4gを得た。分解点240〜245℃(3)4,4′−
[(シクロヘキシル)メチレン]ビス(フェニルグアニ
ジン)二塩酸塩 (2)で製した化合物1.8g、シアナミド0.63g、エタノ
ール10mlの混合物を、アルゴン雰囲気下、封管中、浴温
125℃で15時間加熱した。反応液を減圧濃縮後、残渣に
水を加えた。その水溶液をエーテルで洗浄した後、10%
水酸化ナトリウム水溶液を加え、pH11以上に調整した。
析出したガム状物質を集め、水、クロロホルムで洗浄
後、エタノール−希塩酸の混合溶媒に溶解させた。その
溶液を減圧濃縮後、析出結晶を濾取し、表記化合物1.2g
を得た。融点211−213℃本化合物の物性データを表3に
示す。
(2) 4,4 ′-[(cyclohexyl) methylene] dianiline dihydrochloride 1.8 g of the compound prepared in (1), 10% palladium on carbon 0.3 g,
A mixture of 2 ml of N, N-dimethylformamide and 50 ml of ethanol was shaken under hydrogen-atmosphere at room temperature for 4 hours. After removing the catalyst by filtration, the filtrate was concentrated under reduced pressure. The residue was dissolved in 30 ml of ethanol. 2 ml of concentrated hydrochloric acid was added to the solution, and the solution was concentrated under reduced pressure.
The precipitated crystals were collected by filtration, washed with ether and dried to give the title compound (2.4 g). Decomposition point 240-245 ℃ (3) 4,4'-
[(Cyclohexyl) methylene] bis (phenylguanidine) dihydrochloride (2) A mixture of the compound (1.8 g) prepared in (2), cyanamide (0.63 g), and ethanol (10 ml) in a sealed tube in an argon atmosphere at a bath temperature.
Heated at 125 ° C. for 15 hours. The reaction solution was concentrated under reduced pressure, and water was added to the residue. After washing the aqueous solution with ether, 10%
An aqueous sodium hydroxide solution was added to adjust the pH to 11 or higher.
The precipitated gum-like substance was collected, washed with water and chloroform, and then dissolved in a mixed solvent of ethanol-dilute hydrochloric acid. The solution was concentrated under reduced pressure, and the precipitated crystals were collected by filtration to give the title compound (1.2 g).
Got Melting point 211-213 ° C Table 3 shows the physical property data of this compound.

実施例1と同様の方法で実施例2及び実施例3の化合物
を製造した。後記表2及び表3参照 実施例4 ビス(4−グアニジノフェニル)酢酸二塩酸塩 (1)ビス[4−(3−ベンゾイルグアニジノ)フェニ
ル]酢酸メチル 実施例1と同様の方法で製造したビス(4−アミノフェ
ニル)酢酸メチル1.1g、N−ベンゾイルシアナミド1.5g
のN,N−ジメチルホルムアミド10ml溶液を、90−110℃で
4時間加熱撹拌した。反応液を減圧濃縮後、残渣に水を
加え、酢酸エチルで抽出した。抽出液を水洗し、芒硝で
乾燥後、減圧濃縮した。残渣をシリカゲルカラムクロマ
トグラフィーで精製し、表記化合物1.6gを得た。1 H−NMR(DMSO−d6)δppm: 3.7(3H,s) 5.18(1H,s) 7.25−7.7(14H,m) 8.0−8.2(4H,m) 7.8−8.6(4H,br) 8.9−9.6(2H,br)。
The compounds of Example 2 and Example 3 were produced in the same manner as in Example 1. See Tables 2 and 3 below. Example 4 Bis (4-guanidinophenyl) acetic acid dihydrochloride (1) Methyl bis [4- (3-benzoylguanidino) phenyl] acetate Bis (prepared in the same manner as in Example 1 Methyl 4-aminophenyl) acetate 1.1 g, N-benzoyl cyanamide 1.5 g
A 10 ml solution of N, N-dimethylformamide of was heated and stirred at 90-110 ° C for 4 hours. The reaction mixture was concentrated under reduced pressure, water was added to the residue, and the mixture was extracted with ethyl acetate. The extract was washed with water, dried over Glauber's salt, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give the title compound (1.6 g). 1 H-NMR (DMSO-d 6 ) δppm: 3.7 (3H, s) 5.18 (1H, s) 7.25-7.7 (14H, m) 8.0-8.2 (4H, m) 7.8-8.6 (4H, br) 8.9- 9.6 (2H, br).

(2)ビス(4−グアニジノフェニル)酢酸二塩酸塩 (1)で製した化合物0.96gの6規定塩酸20ml懸濁液を1
3時間加熱還流した。冷後、反応液をエーテルで洗浄
し、減圧濃縮した。沈殿物を濾取し、第三級ブタノー
ル、エーテルで順次洗浄後、乾燥し、表記化合物0.58g
を得た。分解点239−240℃。本化合物の物性データを表
3に示す。
(2) Bis (4-guanidinophenyl) acetic acid dihydrochloride 10.9 ml of 6N hydrochloric acid suspension containing 0.96 g of the compound prepared in (1)
The mixture was heated under reflux for 3 hours. After cooling, the reaction solution was washed with ether and concentrated under reduced pressure. The precipitate is collected by filtration, washed with tertiary butanol and ether in that order, and dried to give the title compound (0.58 g)
Got Decomposition point 239-240 ° C. Table 3 shows the physical property data of this compound.

実施例5 2,2−ビス(4−グアニジノフェニル)エタノール (1)2,2−ビス(4−アミノフェニル)エタノール 水素化アルミニウムリチウム0.48gの無水テトラヒドロ
フラン10ml懸濁液中に、実施例1と同様の方法で製造し
たビス(4−アミノフェニル)酢酸メチル1.3gの無水テ
トラヒドロフラン10ml溶液を10℃以下で滴下した。その
混合物を3時間加熱還流後、氷冷し、次いで水0.5ml、1
5%水酸化ナトリウム水溶液0.5ml、水1.5mlを順次加え
た。不溶物を濾去後、濾液を減圧濃縮した。残渣をシリ
カゲルカラムクロマトグラフィーで精製し次いでエタノ
ールから再結晶して表記化合物0.6gを得た。融点138−1
39.5℃。
Example 5 2,2-Bis (4-guanidinophenyl) ethanol (1) 2,2-Bis (4-aminophenyl) ethanol Example 1 was added to a suspension of 0.48 g of lithium aluminum hydride in 10 ml of anhydrous tetrahydrofuran. A solution of 1.3 g of methyl bis (4-aminophenyl) acetate prepared by the same method in 10 ml of anhydrous tetrahydrofuran was added dropwise at 10 ° C or lower. The mixture was heated under reflux for 3 hours, cooled on ice, then 0.5 ml of water, 1
0.5 ml of a 5% aqueous sodium hydroxide solution and 1.5 ml of water were sequentially added. The insoluble material was filtered off, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography and then recrystallized from ethanol to obtain 0.6 g of the title compound. Melting point 138-1
39.5 ° C.

(2)2,2−ビス(4−グアニジノフェニル)エタノー
ル 実施例4と同様の方法により、(1)で製した化合物か
ら表記化合物を製造した。本化合物の物性データを表3
に示す。
(2) 2,2-Bis (4-guanidinophenyl) ethanol In the same manner as in Example 4, the title compound was produced from the compound produced in (1). Table 3 shows the physical property data of this compound.
Shown in.

実施例6 2,2−ビス(4−グアニジノフェニル)−3−シクロヘ
キシルプロピオン酸エチル二塩酸塩 (1)3−シクロヘキシル−2,2−ジフェニルプロピオ
ン酸エチル ジフェニル酢酸エチル15gの無水N,N−ジメチルホルムア
ミド溶液中に、5℃以下で50%油性水素化ナトリウムを
少量ずつ加えた。同温度で40分間撹拌後、シクロヘキシ
ルメチルヨージド16gの無水N,N−ジメチルホルムアミド
12ml溶液を滴下した。10℃以下で15時間撹拌後、反応液
に塩化アンモニア水溶液を加え、ベンゼンで抽出した。
その抽出液を水洗し芒硝で乾燥後減圧濃縮した。残渣を
シリカゲルカラムクロマトグラフィーで精製し、表記化
合物17gを油状物として得た。1 H−NMR(CDCl3)δppm: 0.6−1.6(11H,m) 1.1(3H,t) 2.25(2H,m) 4.06(2H,q) 7.1−7.5(10H,m) (2)2,2−ビス(4−グアニジノフェニル)−3−シ
クロヘキシルプロピオン酸エチル二塩酸塩 実施例1と同様の方法により、(1)で製した化合物か
ら表記化合物を製造した。本化合物の物性データを表3
に示す。
Example 6 Ethyl 2,2-bis (4-guanidinophenyl) -3-cyclohexylpropionate dihydrochloride (1) Ethyl 3-cyclohexyl-2,2-diphenylpropionate Ethyl diphenylacetate 15 g anhydrous N, N-dimethyl To the formamide solution, 50% oily sodium hydride was added little by little at 5 ° C or lower. After stirring for 40 minutes at the same temperature, 16 g of cyclohexylmethyl iodide anhydrous N, N-dimethylformamide
A 12 ml solution was added dropwise. After stirring at 10 ° C or lower for 15 hours, an aqueous solution of ammonium chloride was added to the reaction solution, and the mixture was extracted with benzene.
The extract was washed with water, dried over Glauber's salt, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give the title compound (17 g) as an oil. 1 H-NMR (CDCl 3 ) δppm: 0.6-1.6 (11H, m) 1.1 (3H, t) 2.25 (2H, m) 4.06 (2H, q) 7.1-7.5 (10H, m) (2) 2,2 -Bis (4-guanidinophenyl) -3-cyclohexylpropionate ethyl dihydrochloride In the same manner as in Example 1, the title compound was produced from the compound produced in (1). Table 3 shows the physical property data of this compound.
Shown in.

実施例7 2,2−ビス(4−グアニジノフェニル)−3−シクロヘ
キシルプロピオン酸塩酸塩 実施例6の化合物1gの10%塩酸溶液を30時間加熱還流し
た。反応液を減圧濃縮後、残渣をエタノールに溶解し活
性炭処理を行なった。処理液を減圧乾固し、表記化合物
0.8gを得た。本化合物の物性データを表3に示す。
Example 7 2,2-Bis (4-guanidinophenyl) -3-cyclohexylpropionate hydrochloride A 10% hydrochloric acid solution of 1 g of the compound of Example 6 was heated under reflux for 30 hours. After the reaction solution was concentrated under reduced pressure, the residue was dissolved in ethanol and treated with activated carbon. The treatment liquid is dried under reduced pressure to give the title compound.
0.8g was obtained. Table 3 shows the physical property data of this compound.

実施例8 3,4′−[(シクロヘキシル)メチレン]ビス(フェニ
ルグアニジン)二塩酸塩 (1)シクロヘキシル 3−ニトロフェニル ケトン 実施例1の(1)と同様の方法で、シクロヘキシル フ
ェニル ケトンから表記化合物を製造した。融点60−62
℃。
Example 8 3,4 ′-[(Cyclohexyl) methylene] bis (phenylguanidine) dihydrochloride (1) Cyclohexyl 3-nitrophenyl ketone In the same manner as in (1) of Example 1, the title compound was converted from cyclohexyl phenyl ketone. Was manufactured. Melting point 60-62
° C.

(2)(シクロヘキシル)(3−ニトロフェニル)メタ
ノール (1)で製した化合物1gのエタノール10ml溶液中に、氷
冷下、水素化ホウ素ナトリウム0.07gを少量ずつ加え
た。室温で30分撹拌後、、エタノールを減圧留去した。
残渣を塩化メチレンに溶解した。その溶液を水洗し、芒
硝で乾燥後、減圧濃縮して表記化合物1gを黄色油状物と
して得た。1 H−NMR(CDCl3)δppm: 0.8−2.0(11H,m) 2.91(1H,br) 4.49(1H,d) 7.3−7.7,7.95−8.2(4H,m) (3)1−[(シクロヘキシル)(フェニル)メチル]
−3−ニトロベンゼン (2)で製した化合物6.2gのベンゼン30ml溶液中に、10
−15℃で無水塩化アルミニウム4.3gを少量ずつ加えた。
同温度で40分撹拌後、さらに無水塩化アルミニウム3.7g
を加えた。15−20℃で30分撹拌後、氷水中に注ぎ、ベン
ゼンで抽出した。抽出液を水洗し芒硝で乾燥、減圧濃縮
して表記化合物7.4gを黄色油状物として得た。1 H−NMR(CDCl3)δppm: 0.6−1.9(10H,m) 1.9−2.4(1H,m) 3.58(1H,d) 7.1−7.65(7H,m) 7.92(1H,d) 8.12(1H,t) (4)3,4′−[(シクロヘキシル)メチレン]ビス
(フェニルグアニジン)二塩酸塩 実施例1と同様の方法で、(3)で製した化合物から表
記化合物を製造した。本化合物の物性データを表3に示
す。
(2) (Cyclohexyl) (3-nitrophenyl) methanol To a solution of 1 g of the compound prepared in (1) in 10 ml of ethanol, 0.07 g of sodium borohydride was added little by little under ice cooling. After stirring at room temperature for 30 minutes, ethanol was distilled off under reduced pressure.
The residue was dissolved in methylene chloride. The solution was washed with water, dried over sodium sulfate, and concentrated under reduced pressure to give the title compound (1 g) as a yellow oil. 1 H-NMR (CDCl 3 ) δppm: 0.8-2.0 (11H, m) 2.91 (1H, br) 4.49 (1H, d) 7.3-7.7,7.95-8.2 (4H, m) (3) 1-[(cyclohexyl ) (Phenyl) methyl]
-3-Nitrobenzene (2) In a benzene 30 ml solution of the compound 6.2 g, 10
At -15 ° C, 4.3 g of anhydrous aluminum chloride was added little by little.
After stirring for 40 minutes at the same temperature, 3.7 g of anhydrous aluminum chloride
Was added. After stirring at 15-20 ° C for 30 minutes, the mixture was poured into ice water and extracted with benzene. The extract was washed with water, dried over Glauber's salt, and concentrated under reduced pressure to obtain 7.4 g of the title compound as a yellow oil. 1 H-NMR (CDCl 3 ) δppm: 0.6-1.9 (10H, m) 1.9-2.4 (1H, m) 3.58 (1H, d) 7.1-7.65 (7H, m) 7.92 (1H, d) 8.12 (1H, t) (4) 3,4 '-[(Cyclohexyl) methylene] bis (phenylguanidine) dihydrochloride In the same manner as in Example 1, the title compound was prepared from the compound prepared in (3). Table 3 shows the physical property data of this compound.

実施例9 4−[(シクロヘキシル)(4−グアニジノフェニル)
メチル]−2−メトキシフエニルグアニジン二塩酸塩 (1)3−[(シクロヘキシル)(フェニル)メチル]
フェノール 実施例1の(2)と同様の方法により、実施例8の
(3)の化合物から3−[(シクロヘキシル)(フェニ
ル)メチル]アニリンを製造した。この化合物1gの酢酸
10ml溶液を、−5℃で亜硝酸ナトリウム1gの濃硫酸10ml
溶液に滴下した。酢酸10mlを追加し、同温度で1.5時間
撹拌後、その反応液を尿素0.6gの水50ml溶液中に0℃で
滴下した。同温度で1時間撹拌後、80℃の湯50ml中にそ
の温度を保ちつつ、反応液を滴下した。同温度で1時間
撹拌後、析出油状物をエーテルで抽出した。その抽出液
を水洗し乾燥後、減圧濃縮した。残渣をシリカゲルカラ
ムクロマトグラフィーで精製し、表記化合物0.5gを油状
物として得た。1 H−NMR(CDCl3)δppm: 0.6−2.1(11H,m) 3.35(1H,d) 6.45(1H,d) 6.7(1H,s) 6.85(1H,d) 7.0,7.13(6H,m) (2)1−[(シクロヘキシル)(フェニル)メチル]
−3−メトキシベンゼン (1)で製した化合物0.36gのエタノール8ml溶液中に、
1規定水酸化ナトリウム水溶液5ml及びジメチル硫酸0.3
mlを室温で交互に加えた。その反応液を3時間加熱還流
後、水を加え、ベンゼンで抽出した。抽出液を水洗し芒
硝で乾燥後、減圧留去し、表記化合物0.3gを油状物とし
て得た。1H−NMR(CDCl3)δppm: 0.6−2.1(11H,m) 3.4(1H,d) 3.66(3H,s) 6.57(1H,d.d) 6.7−7.2(8H,m) (3)1−[(シクロヘキシル)(4−ニトロフェニ
ル)メチル]−3−メトキシ−4−ニトロベンゼン (2)で製した化合物2.3gの無水酢酸10ml溶液中に、70
%硝酸2mlの無水酢酸5ml混液を−10℃で滴下した。同温
度で30分撹拌後、室温で一晩撹拌した。以下、実施例1
の(1)と同様の後処理を行い、表記化合物1.2gを油状
物として得た。1 H−NMR(CDCl3)δppm: 0.8−1.7(10H,m) 2−2.4(1H,m) 3.73(1H,d) 3.95(3H,s) 6.98(1H,d,) 7.01(1H,s) 7.45(2H,d) 7.75(1H,d) 8.07(2H,d) (4)4−[(シクロヘキシル)(4−アミノフェニ
ル)メチル]−2−メトキシアニリン二塩酸塩 (3)で製した化合物0.9gの酢酸6ml溶液に、塩化第一
スズ3.3gの濃塩酸6ml溶液を室温で滴下した。70−80℃
で4時間撹拌後、氷水中に注ぎ、水酸化ナトリウム水溶
液を加え、pH11以上に調整し、ベンゼンで抽出した。抽
出液を水洗し芒硝で乾燥後、減圧濃縮した。残渣をシリ
カゲルカラムクロマトグラフィーで精製した後、メタノ
ール−塩酸で処理し、表記化合物0.76gを得た。分解点1
80(着色開始)−195℃。
Example 9 4-[(Cyclohexyl) (4-guanidinophenyl)
Methyl] -2-methoxyphenylguanidine dihydrochloride (1) 3-[(cyclohexyl) (phenyl) methyl]
Phenol In the same manner as in (2) of Example 1, 3-[(cyclohexyl) (phenyl) methyl] aniline was produced from the compound of (8) in Example 8. 1 g of this compound acetic acid
10ml solution at -5 ° C, 1g sodium nitrite, 10ml concentrated sulfuric acid
Dropped into the solution. After adding 10 ml of acetic acid and stirring at the same temperature for 1.5 hours, the reaction solution was added dropwise to a solution of 0.6 g of urea in 50 ml of water at 0 ° C. After stirring at the same temperature for 1 hour, the reaction solution was added dropwise to 50 ml of hot water at 80 ° C while maintaining the temperature. After stirring at the same temperature for 1 hour, the precipitated oily substance was extracted with ether. The extract was washed with water, dried, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give the title compound (0.5 g) as an oil. 1 H-NMR (CDCl 3 ) δppm: 0.6-2.1 (11H, m) 3.35 (1H, d) 6.45 (1H, d) 6.7 (1H, s) 6.85 (1H, d) 7.0,7.13 (6H, m) (2) 1-[(cyclohexyl) (phenyl) methyl]
-3-Methoxybenzene (1) In a solution of 0.36 g of the compound prepared in (8) in 8 ml of ethanol,
5 ml of 1N aqueous sodium hydroxide solution and dimethylsulfate 0.3
ml was added alternately at room temperature. The reaction solution was heated under reflux for 3 hours, water was added, and the mixture was extracted with benzene. The extract was washed with water, dried over sodium sulfate, and evaporated under reduced pressure to give the title compound (0.3 g) as an oil. 1 H-NMR (CDCl 3 ) δppm: 0.6-2.1 (11H, m) 3.4 (1H, d) 3.66 (3H, s) 6.57 (1H, dd) 6.7-7.2 (8H, m) (3) 1- [ (Cyclohexyl) (4-nitrophenyl) methyl] -3-methoxy-4-nitrobenzene (2) To a solution of 2.3 g of the compound in 10 ml of acetic anhydride, 70
A mixed solution of 2 ml of% nitric acid and 5 ml of acetic anhydride was added dropwise at -10 ° C. After stirring at the same temperature for 30 minutes, the mixture was stirred at room temperature overnight. Hereinafter, Example 1
The post-treatment was carried out in the same manner as in (1) above to obtain 1.2 g of the title compound as an oil. 1 H-NMR (CDCl 3 ) δppm: 0.8-1.7 (10H, m) 2-2.4 (1H, m) 3.73 (1H, d) 3.95 (3H, s) 6.98 (1H, d,) 7.01 (1H, s ) 7.45 (2H, d) 7.75 (1H, d) 8.07 (2H, d) (4) 4-[(cyclohexyl) (4-aminophenyl) methyl] -2-methoxyaniline dihydrochloride (3) To a solution of 0.9 g of the compound in 6 ml of acetic acid, a solution of 3.3 g of stannous chloride in 6 ml of concentrated hydrochloric acid was added dropwise at room temperature. 70-80 ° C
After stirring for 4 hours, the mixture was poured into ice water, a sodium hydroxide aqueous solution was added to adjust the pH to 11 or higher, and the mixture was extracted with benzene. The extract was washed with water, dried over Glauber's salt, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography and then treated with methanol-hydrochloric acid to obtain 0.76 g of the title compound. Decomposition point 1
80 (start of coloring) -195 ° C.

(5)4−[(シクロヘキシル)(4−グアニジノフェ
ニル)メチル]−2−メトキシフェニルグアニジン二塩
酸塩 実施例1の(3)と同様の方法で、(4)で製した化合
物より表記化合物を製造した。本化合物の物性データを
表3に示す。
(5) 4-[(cyclohexyl) (4-guanidinophenyl) methyl] -2-methoxyphenylguanidine dihydrochloride In the same manner as in (3) of Example 1, the title compound was prepared from the compound prepared in (4). Manufactured. Table 3 shows the physical property data of this compound.

実施例10 2−[3−シクロヘキシル−1−(4−グアニジノフェ
ニル)プロピル]−5−グアニジノ安息香酸二塩酸塩 (1)2−(2−ブロモフェニル)−2−フェニルアセ
トアルデヒド メトキシメチルトリフェニルホスホニウムクロリド11g
の無水エーテル50ml懸濁液中に、窒素気流下、0℃で、
ブチルリチウムの1.8モルヘキサン溶液18mlを滴下し
た。同温度で1時間撹拌後、2−ブロモベンゾフェノン
5.5gの無水エーテル50ml溶液をその混合物中に滴下し
た。同温度で3時間撹拌後、水を加えた。エーテル層を
分取し、水洗して芒硝で乾燥後減圧濃縮した。残渣をシ
リカゲルカラムクロマトグラフィーで精製し、1−ブロ
モ−2−[(2−メトキシ−1−フェニル)エテニル]
ベンゼン5.2gを得た。これをエーテル200mlに溶解し
た。その溶液に70%過塩素酸50mlで氷冷下滴下した。そ
の混合物を室温で3時間撹拌後、氷水中に注ぎベンゼン
で抽出した。抽出液を水洗し芒硝で乾燥後、減圧濃縮し
た。残渣をシリカゲルカラムクロマトグラフィーで精製
し、表記化合物3.4gを油状物として得た。1 H−NMR(CDCl3)δppm: 5.36(1H,s) 7.2(8H,br) 7.5(1H,br) 9.82(1H,s) (2)1−ブロモ−2−(3−シクロヘキシル−1−フ
ェニル−2−プロペン−1−イル)ベンゼン アルゴン雰囲気下、シクロヘキシルメチルトリフェニル
ホスホニウムブロミド1gの無水エーテル4ml懸濁液中
に、ブチルリチウムの1.6モルヘキサン溶液1.4mlを加
え、室温で2時間撹拌した。この混合物中に、(1)で
製した化合物0.3gの無水エーテル2ml溶液を加え、室温
で2時間撹拌後、一晩放置した。反応液に水を加え、エ
ーテルで抽出した。その抽出液を水洗し芒硝で乾燥後、
減圧濃縮した。残渣をシリカゲルカラムクロマトグラフ
ィーで精製し、表記化合物0.1gを油状物として得た。1 H−NMR(CDCl3)δppm: 1.12,1.6(10H,br) 2.4(1H,br) 5.0−5.7(3H,m) 7.0(8H,br) 7.45(1H,d) (3)2−(3−シクロヘキシル−1−フェニル−2−
プロペン−1−イル)ベンゾニトニル (2)で製した化合物5.5g、シアン化第一銅1.4g、ジメ
チルホルムアミド25mlの混合物を窒素雰囲気下、8時間
加熱還流した。その混合物に氷水を加え、ベンゼンで抽
出した。抽出液を水洗し芒硝で乾燥後減圧濃縮した。残
渣をシリカゲルカラムクロマトグラフィーで精製し、表
記化合物3.7gを油状物として得た。1 H−NMR(CDCl3)δppm: 1.2,1.6(10H,br) 2.5(1H,br) 5.05−5.7(3H,m) 7.18(7H,br) 7.38(1H,d) 7.53(1H,d) (4)2−(3−シクロヘキシル−1−フェニルプロピ
ル)ベンゾニトリル (3)で製した化合物3.6g、10%パラジウム炭素0.4g、
メタノール30mlの混合物を水素三気圧下、室温で7時間
振盪した。触媒を濾去後、瀘液を減圧濃縮し、表記化合
物2.9gを油状物として得た。1 H−NMR(CDCl3)δppm: 1.2,1.6(13H,br) 2.1(2H,br) 4.32(1H,t) 7.2(9H,br) (5)2−[3−シクロヘキシル−1−(4−グアニジ
ノフェニル)プロピル]−5−グアニジノベンゾニトリ
ル二塩酸塩 実施例1と同様の方法で、(4)で製した化合物から表
記化合物を製造した。融点155−160℃。
Example 10 2- [3-Cyclohexyl-1- (4-guanidinophenyl) propyl] -5-guanidinobenzoic acid dihydrochloride (1) 2- (2-bromophenyl) -2-phenylacetaldehyde methoxymethyltriphenylphosphonium Chloride 11g
In 50 ml of anhydrous ether under a nitrogen stream at 0 ° C.
18 ml of a 1.8 mol hexane solution of butyl lithium was added dropwise. After stirring for 1 hour at the same temperature, 2-bromobenzophenone
A solution of 5.5 g of 50 ml of anhydrous ether was added dropwise into the mixture. After stirring at the same temperature for 3 hours, water was added. The ether layer was separated, washed with water, dried over sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel column chromatography, 1-bromo-2-[(2-methoxy-1-phenyl) ethenyl].
5.2 g of benzene was obtained. This was dissolved in 200 ml of ether. 50 ml of 70% perchloric acid was added dropwise to the solution under ice cooling. The mixture was stirred at room temperature for 3 hours, poured into ice water and extracted with benzene. The extract was washed with water, dried over Glauber's salt, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give the title compound (3.4 g) as an oil. 1 H-NMR (CDCl 3 ) δppm: 5.36 (1H, s) 7.2 (8H, br) 7.5 (1H, br) 9.82 (1H, s) (2) 1-bromo-2- (3-cyclohexyl-1-) (Phenyl-2-propen-1-yl) benzene In an argon atmosphere, 1.4 ml of a 1.6 mol hexane solution of butyllithium was added to a suspension of 1 g of cyclohexylmethyltriphenylphosphonium bromide in 4 ml of anhydrous ether, and the mixture was stirred at room temperature for 2 hours. A solution of 0.3 g of the compound prepared in (1) in 2 ml of anhydrous ether was added to this mixture, and the mixture was stirred at room temperature for 2 hours and then left overnight. Water was added to the reaction solution, which was extracted with ether. After washing the extract with water and drying with Glauber's salt,
It was concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give the title compound (0.1 g) as an oil. 1 H-NMR (CDCl 3 ) δppm: 1.12,1.6 (10H, br) 2.4 (1H, br) 5.0-5.7 (3H, m) 7.0 (8H, br) 7.45 (1H, d) (3) 2- ( 3-cyclohexyl-1-phenyl-2-
A mixture of 5.5 g of the compound prepared from (propen-1-yl) benzonitonyl (2), 1.4 g of cuprous cyanide and 25 ml of dimethylformamide was heated under reflux for 8 hours under a nitrogen atmosphere. Ice water was added to the mixture, and the mixture was extracted with benzene. The extract was washed with water, dried over Glauber's salt, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give the title compound (3.7 g) as an oil. 1 H-NMR (CDCl 3 ) δppm: 1.2,1.6 (10H, br) 2.5 (1H, br) 5.05-5.7 (3H, m) 7.18 (7H, br) 7.38 (1H, d) 7.53 (1H, d) (4) 2- (3-Cyclohexyl-1-phenylpropyl) benzonitrile 3.6 g of the compound prepared in (3), 0.4 g of 10% palladium carbon,
A mixture of 30 ml of methanol was shaken under 3 atm of hydrogen at room temperature for 7 hours. After removing the catalyst by filtration, the filtrate was concentrated under reduced pressure to give the title compound (2.9 g) as an oil. 1 H-NMR (CDCl 3 ) δppm: 1.2,1.6 (13H, br) 2.1 (2H, br) 4.32 (1H, t) 7.2 (9H, br) (5) 2- [3-cyclohexyl-1- (4 -Guanidinophenyl) propyl] -5-guanidinobenzonitrile dihydrochloride In the same manner as in Example 1, the title compound was produced from the compound produced in (4). Melting point 155-160 [deg.] C.

(6)2−[3−シクロヘキシル−1−(4−グアニジ
ノフェニル)プロピル]−5−グアニジノ安息香酸二塩
酸塩 (5)で製した化合物1.2gの濃塩酸25ml溶液を、封管
中、120℃で一晩加熱撹拌した。反応液を減圧濃縮した
後、残渣を高速液体クロマトグラフィー(カラム:マイ
クロボンダパックC18)で精製し次いでエーテルで粉末
化させて表記化合物0.5gを得た。本化合の物性データを
表3に示す。
(6) 2- [3-Cyclohexyl-1- (4-guanidinophenyl) propyl] -5-guanidinobenzoic acid dihydrochloride A solution of 1.2 g of the compound prepared in (5) in concentrated hydrochloric acid (25 ml) was charged in a sealed tube at 120 The mixture was heated with stirring at 0 ° C overnight. The reaction mixture was concentrated under reduced pressure, the residue was purified by high performance liquid chromatography (column: Microbonder pack C 18 ) and then powdered with ether to give the title compound (0.5 g). Table 3 shows the physical property data of this compound.

実施例11 2−[3−シクロヘキシル−1−(4−グアニジノフェ
ニル)プロピル]−N,N−ジメチル−5−グアニジノベ
ンズアミド二塩酸塩 (1)2−[3−シクロヘキシル−1−(4−ニトロフ
ェニル)プロピル]−5−ニトロ安息香酸 実施例10の(4)で製した化合物を、実施例1の(1)
の方法で処理し、2−[3−シクロヘキシル−1−(4
−ニトロフェニル)プロピル)−5−ニトロベンゾニト
リルを製した。本化合物8.4gの酢酸100ml溶液を80%硫
酸60ml溶液中に加え、120℃で2時間加熱撹拌した。氷
冷後、3モル亜硝酸ナトリウム水溶液10mlを加え、室温
で2時間撹拌した。反応液を氷水中に注ぎ、クロロホル
ムで抽出した。抽出液を水洗し芒硝で乾燥後減圧留去し
た。残渣をシリカゲルカラムクロマトグラフィーで精製
し、表記化合物4.5gをアモルファスとして得た。1 H−NMR(CDCl3)δppm: 1.1−2.1(15H,m) 5.3(1H,t) 7.4(2H,d) 7.53(1H,d) 8.06(2H,d) 8.26(1H,d.d) 8.76(1H,d) (2)2−[3−シクロヘキシル−1−(4−ニトロフ
ェニル)プロピル]−N,N−ジメチル−5−ニトロベン
ズアミド (1)で製した化合物4.4gと塩化チオニル10mlの混合物
を1時間加熱還流した。反応液を減圧乾固し、残渣にジ
オキサン5mlを加えた。その溶液に50%ジメチルアミン
水溶液10mlを加え、室温で1時間撹拌した。反応液を減
圧濃縮し、残渣をクロロホルムで抽出した。その抽出液
を水、希塩酸、水で順次洗浄し芒硝で乾燥後減圧乾固し
て表記化合物3.6gを油状物として得た。1 H−NMR(CDCl3)δppm: 1.1−2.1(15H,m) 3.07(3H,s) 3.69(3H,s) 4.4(1H,br) 7.3−7.8(3H,m) 8.0−8.3(4H,m) (3)2−[3−シクロヘキシル−1−(4−グアニジ
ノフェニル)プロピル]−N,N−ジメチル−5−グアニ
ジノベンズアミド二塩酸塩 実施例1と同様の方法で、(2)で製した化合物から表
記化合物を製造した。本化合物の物性データを表3に示
す。
Example 11 2- [3-Cyclohexyl-1- (4-guanidinophenyl) propyl] -N, N-dimethyl-5-guanidinobenzamide dihydrochloride (1) 2- [3-Cyclohexyl-1- (4-nitro (Phenyl) propyl] -5-nitrobenzoic acid The compound prepared in Example 10 (4) was converted to Example 1 (1).
2- [3-cyclohexyl-1- (4
-Nitrophenyl) propyl) -5-nitrobenzonitrile was prepared. A solution of 8.4 g of this compound in 100 ml of acetic acid was added to a 60 ml solution of 80% sulfuric acid, and the mixture was heated with stirring at 120 ° C. for 2 hours. After cooling with ice, 10 ml of a 3 molar aqueous sodium nitrite solution was added, and the mixture was stirred at room temperature for 2 hours. The reaction solution was poured into ice water and extracted with chloroform. The extract was washed with water, dried over Glauber's salt and evaporated under reduced pressure. The residue was purified by silica gel column chromatography to give the title compound (4.5 g) as an amorphous substance. 1 H-NMR (CDCl 3 ) δppm: 1.1-2.1 (15H, m) 5.3 (1H, t) 7.4 (2H, d) 7.53 (1H, d) 8.06 (2H, d) 8.26 (1H, dd) 8.76 ( 1H, d) (2) 2- [3-Cyclohexyl-1- (4-nitrophenyl) propyl] -N, N-dimethyl-5-nitrobenzamide A mixture of 4.4 g of the compound prepared in (1) and 10 ml of thionyl chloride. Was heated to reflux for 1 hour. The reaction solution was dried under reduced pressure, and 5 ml of dioxane was added to the residue. To the solution was added 10 ml of 50% aqueous dimethylamine solution, and the mixture was stirred at room temperature for 1 hour. The reaction solution was concentrated under reduced pressure, and the residue was extracted with chloroform. The extract was washed successively with water, diluted hydrochloric acid and water, dried over sodium sulfate and dried under reduced pressure to give 3.6 g of the title compound as an oil. 1 H-NMR (CDCl 3 ) δppm: 1.1-2.1 (15H, m) 3.07 (3H, s) 3.69 (3H, s) 4.4 (1H, br) 7.3-7.8 (3H, m) 8.0-8.3 (4H, m) (3) 2- [3-Cyclohexyl-1- (4-guanidinophenyl) propyl] -N, N-dimethyl-5-guanidinobenzamide dihydrochloride Prepared in (2) in the same manner as in Example 1. The title compound was prepared from the above compound. Table 3 shows the physical property data of this compound.

実施例12 2−[(シクロヘキシル)(4−グアニジノフェニル)
メチル]−5−グアニジノピリジン二塩酸塩 (1)6−[(シクロヘキシル)(フェニル)メチル−
1,2−ジヒドロ−2−オキソ−3−ピリジンカルボニト
リル 50%油性水素化ナトリウム23.5gの無水ベンゼン300ml懸
濁液中に、5−15℃で1−シクロヘキシル−1−フェニ
ル−2−プロパノン96gとギ酸エチル54gの混合液を、1
時間を要し、滴下した。同温度で2時間撹拌後、一晩放
置した。その反応液に水200mlを加え、水層を分取し
た。有機層を水100mlで3回抽出した。水層を合わせ、
エーテルで3回洗浄した後、シアノアセトアミド38g、
N,N−ジイソプロピルエチルアミン65g、酢酸9mlを室温
で加えた。その混合物中の低沸点物質(沸点98℃までの
留分)を留去した後、4時間加熱還流した。冷後、反応
液に酢酸を加えpH4に調整しクロロホルムで抽出した。
抽出液を水洗し、芒硝で乾燥後減圧濃縮した。残渣をカ
ラムクロマトグラフィーで精製後、クロロホルム−エー
テルから再結晶し、表記化合物17gを得た。融点244−24
6℃。
Example 12 2-[(Cyclohexyl) (4-guanidinophenyl)
Methyl] -5-guanidinopyridine dihydrochloride (1) 6-[(cyclohexyl) (phenyl) methyl-
1,2-Dihydro-2-oxo-3-pyridinecarbonitrile 50% Oily sodium hydride 23.5 g In a suspension of 300 ml of anhydrous benzene, at 5-15 ° C, 1-cyclohexyl-1-phenyl-2-propanone 96 g And a mixture of ethyl formate 54g 1
It took time and was dripped. After stirring at the same temperature for 2 hours, the mixture was left overnight. 200 ml of water was added to the reaction solution, and the aqueous layer was separated. The organic layer was extracted 3 times with 100 ml of water. Combine the water layers,
After washing 3 times with ether, 38 g of cyanoacetamide,
65 g of N, N-diisopropylethylamine and 9 ml of acetic acid were added at room temperature. The low-boiling substance (fraction up to boiling point 98 ° C.) in the mixture was distilled off, and the mixture was heated under reflux for 4 hours. After cooling, acetic acid was added to the reaction solution to adjust the pH to 4, and the mixture was extracted with chloroform.
The extract was washed with water, dried over Glauber's salt, and concentrated under reduced pressure. The residue was purified by column chromatography and recrystallized from chloroform-ether to give the title compound (17 g). Melting point 244-24
6 ° C.

(2)2−クロロ−6−[(シクロヘキシル)(フェニ
ル)メチル]−3−ピリジンカルボニトリル (1)で製した化合物1.1g、五塩化リン1g、オキシ塩化
リン0.25ml、クロロベンゼン5mlの混合物を5時間加熱
還流した。冷後、氷水中に注ぎ、重曹末を加え、pH9に
調整、クロロホルムで抽出した。抽出液を水洗し、芒硝
で乾燥後減圧濃縮した。残渣をカラムクロマトグラフィ
ーで精製し、表記化合物0.9gを油状物として得た。1 H−NMR(CDCl3)δppm: 0.6−1.9(10H,m) 2.1−2.6(1H,m) 3.67(1H,d) 7.1−7.4(6H,m) 7.8(1H,d) (3)2−クロロ−6−[(シクロヘキシル)(フェニ
ル)メチル]−3−ピリジンカルボンアミド (2)で製した化合物0.9gのメタノール6ml溶液中に、2
0%水酸化ナトリウム0.7ml、35%過酸化水素水0.8mlの
混合液を室温で滴下した。同温度で1時間撹拌後、水を
加え、クロロホルムで抽出した。抽出液を水洗し、芒硝
で乾燥後減圧濃縮し、表記化合物をアモルファスとして
得た。1 H−NMR(CDCl3)δppm: 0.7−1.8(10H,m) 2.1−2.5(1H,m) 3.66(1H,d) 6.67(2H,br) 7.15−7.5(6H,m) 8.02(1H,d) (4)6−[(シクロヘキシル)(4−ニトロフェニ
ル)メチル]−3−ピリジンカルボンアミド 実施例1の(2)と同様の方法で、(3)で製した化合
物を接触還元し、6−[(シクロヘキシル)(フェニ
ル)メチル]−3−ピリジンカルボンアミドを得た。次
いで、本化合物を実施例1の(1)と同様の方法で処理
し、表記化合物を得た。1 H−NMR(CDCl3)δppm: 0.6−1.9(10H,m) 2.1−2.6(1H,m) 3.8(1H,d) 6.4(2H,br) 7.28(1H,d) 7.61(2H,d) 8.03(1H,d.d) 8.12(2H,d) 9.01(1H,d) (5)3−アミノ−6−[(シクロヘキシル)(4−ニ
トロフェニル)メチル]ピリジン 二規定水酸化ナトリウム水溶液72ml中に、臭素2gを−5
℃で滴下した。臭素溶解後、(4)で製した化合物3.2g
のジオキサン16ml溶液を同温度で滴下した。0℃で30
分、10℃で30分、30℃で30分、70℃で2時間撹拌した。
その反応液を減圧濃縮後、酢酸を加えpH7、次いで炭酸
カリウムでpH10に調整し、クロロホルムで抽出した。抽
出液を水洗し芒硝で乾燥後、減圧濃縮した。残渣をシリ
カゲルカラムクロマトグラフィーで精製し、表記化合物
1gをアモルファスとして得た。1 H−NMR(CDCl3)δppm: 0.6−1.9(10H,m) 2.1−2.6(1H,m) 3.3−3.9(2H,br) 3.65(2H,d) 6.89(1H,d.d) 7.0(1H,d.d) 7.60(2H,d.) 8.08(1H,s) 8.13(2H,d) (6)2−[(シクロヘキシル)(4−グアニジノフェ
ニル)メチル]−5−グアニジノピリジン二塩酸塩 実施例4と同様の方法で、(5)で製した化合物から表
記化合物を製造した。本化合物の物性データを表3に示
す。
(2) 2-chloro-6-[(cyclohexyl) (phenyl) methyl] -3-pyridinecarbonitrile A mixture of 1.1 g of the compound prepared in (1), 1 g of phosphorus pentachloride, 0.25 ml of phosphorus oxychloride and 5 ml of chlorobenzene was added. The mixture was heated under reflux for 5 hours. After cooling, it was poured into ice water, sodium bicarbonate powder was added to adjust the pH to 9, and the mixture was extracted with chloroform. The extract was washed with water, dried over Glauber's salt, and concentrated under reduced pressure. The residue was purified by column chromatography to give the title compound (0.9 g) as an oil. 1 H-NMR (CDCl 3 ) δppm: 0.6-1.9 (10H, m) 2.1-2.6 (1H, m) 3.67 (1H, d) 7.1-7.4 (6H, m) 7.8 (1H, d) (3) 2 -Chloro-6-[(cyclohexyl) (phenyl) methyl] -3-pyridinecarboxamide (2) was added to a solution of 0.9 g of the compound prepared in (2) in 6 ml of methanol,
A mixed solution of 0% sodium hydroxide 0.7 ml and 35% hydrogen peroxide water 0.8 ml was added dropwise at room temperature. After stirring at the same temperature for 1 hour, water was added and the mixture was extracted with chloroform. The extract was washed with water, dried over sodium sulfate and concentrated under reduced pressure to give the title compound as an amorphous substance. 1 H-NMR (CDCl 3 ) δppm: 0.7-1.8 (10H, m) 2.1-2.5 (1H, m) 3.66 (1H, d) 6.67 (2H, br) 7.15-7.5 (6H, m) 8.02 (1H, d) (4) 6-[(Cyclohexyl) (4-nitrophenyl) methyl] -3-pyridinecarbonamide In the same manner as in (2) of Example 1, the compound produced in (3) was catalytically reduced, 6-[(Cyclohexyl) (phenyl) methyl] -3-pyridinecarbonamide was obtained. Then, this compound was treated in the same manner as in (1) of Example 1 to obtain the title compound. 1 H-NMR (CDCl 3 ) δppm: 0.6-1.9 (10H, m) 2.1-2.6 (1H, m) 3.8 (1H, d) 6.4 (2H, br) 7.28 (1H, d) 7.61 (2H, d) 8.03 (1H, dd) 8.12 (2H, d) 9.01 (1H, d) (5) 3-amino-6-[(cyclohexyl) (4-nitrophenyl) methyl] pyridine In 72 ml of 2N aqueous sodium hydroxide solution, Bromine 2g-5
Dropwise at ° C. 3.2 g of the compound prepared in (4) after dissolution of bromine
A 16 ml solution of dioxane in was added dropwise at the same temperature. 30 at 0 ° C
Min, 10 ° C. for 30 minutes, 30 ° C. for 30 minutes, and 70 ° C. for 2 hours.
The reaction solution was concentrated under reduced pressure, pH was adjusted to 7 with acetic acid and then with potassium carbonate, and extracted with chloroform. The extract was washed with water, dried over Glauber's salt, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography to give the title compound.
1 g was obtained as an amorphous. 1 H-NMR (CDCl 3 ) δppm: 0.6-1.9 (10H, m) 2.1-2.6 (1H, m) 3.3-3.9 (2H, br) 3.65 (2H, d) 6.89 (1H, dd) 7.0 (1H, dd) 7.60 (2H, d.) 8.08 (1H, s) 8.13 (2H, d) (6) 2-[(cyclohexyl) (4-guanidinophenyl) methyl] -5-guanidinopyridine dihydrochloride Example 4 and The title compound was prepared from the compound prepared in (5) in the same manner. Table 3 shows the physical property data of this compound.

フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 31/235 9454−4C 31/275 9454−4C 31/44 ACB Continuation of the front page (51) Int.Cl. 6 Identification code Office reference number FI Technical display location A61K 31/235 9454-4C 31/275 9454-4C 31/44 ACB

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】式 [式中、Z1及びZ2はそれそれ独立に=CH−又は=N−
を、R1は水素原子又は式−Q−R5(式中、Qは単結合又
はアルキレン基を、R5は低級アルキル基が置換してもよ
い環状アルキル基を意味する。)で示される基、アルコ
キシカルボニル基、カルボキシル基、ヒドロキシアルキ
ル基またはアルキル基を、R2は水素原子、アルコキシカ
ルボニル基又はカルボキシル基を意味し、該R2はR1と一
緒になってアルキレン基を形成してもよく、R3及びR4
それぞれ独立に水素原子、ハロゲン原子、アルキル基、
アルコキシ基、カルボキシル基、シアノ基又は式 (式中、R6及びR7はそれぞれ独立に水素原子又はアルキ
ル基を意味する。)で示される基を意味する。但し、R1
及びR2が水素原子、Zが=CH−でR3及びR4が水素原子で
ある組合せを除く。]で示される化合物及びその塩。
1. A formula [Wherein Z 1 and Z 2 are independently = CH- or = N-
R 1 is a hydrogen atom or a formula —Q—R 5 (wherein Q represents a single bond or an alkylene group, and R 5 represents a cyclic alkyl group which may be substituted with a lower alkyl group). A group, an alkoxycarbonyl group, a carboxyl group, a hydroxyalkyl group or an alkyl group, R 2 means a hydrogen atom, an alkoxycarbonyl group or a carboxyl group, and R 2 together with R 1 forms an alkylene group. Also, R 3 and R 4 are each independently a hydrogen atom, a halogen atom, an alkyl group,
Alkoxy group, carboxyl group, cyano group or formula (In the formula, R 6 and R 7 each independently represent a hydrogen atom or an alkyl group.). However, R 1
And R 2 is a hydrogen atom, Z is ═CH—, and R 3 and R 4 are hydrogen atoms. ] The compound and its salt shown by these.
JP31299586A 1986-12-27 1986-12-27 Guanidine derivative and its salt Expired - Fee Related JPH0791260B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP31299586A JPH0791260B2 (en) 1986-12-27 1986-12-27 Guanidine derivative and its salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31299586A JPH0791260B2 (en) 1986-12-27 1986-12-27 Guanidine derivative and its salt

Publications (2)

Publication Number Publication Date
JPS63166855A JPS63166855A (en) 1988-07-11
JPH0791260B2 true JPH0791260B2 (en) 1995-10-04

Family

ID=18035965

Family Applications (1)

Application Number Title Priority Date Filing Date
JP31299586A Expired - Fee Related JPH0791260B2 (en) 1986-12-27 1986-12-27 Guanidine derivative and its salt

Country Status (1)

Country Link
JP (1) JPH0791260B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1325859B1 (en) 2001-11-13 2017-03-22 Nissan Motor Co., Ltd. Front body structure for vehicle enhancing the absorbing efficiency of the energy in case of a collision
AR065785A1 (en) * 2007-03-19 2009-07-01 Xenon Pharmaceuticals Inc BIARETO AND BIHETEROARILE COMPOUNDS OF UTILITY IN THE TREATMENT OF IRON DISORDERS
WO2011068211A1 (en) * 2009-12-04 2011-06-09 大正製薬株式会社 2-pyridone compounds

Also Published As

Publication number Publication date
JPS63166855A (en) 1988-07-11

Similar Documents

Publication Publication Date Title
JP3586288B2 (en) Preparation of biphenyl derivatives
Cho et al. Synthesis and antiproliferative activity of new aminoisoquinolinylurea derivatives against melanoma cell line
JPH0791260B2 (en) Guanidine derivative and its salt
CN107383097A (en) The preparation method of the phosphonylation derivative of the ketone of 3 benzylidene iso-indoles of N phenyl 1
JP3029894B2 (en) Method for producing novel 2-hydroxymethyl-4-methoxy-3,5-dimethylpyridine, intermediates for producing the same, and methods for producing them
JPH0641135A (en) Imidazopteridine derivative and its production
JPH0782268A (en) Production of benzothiadiazole derivative
JPH033674B2 (en)
SK15832002A3 (en) Method for the production of trifluoroethoxy-substituted benzoic acids
JP2501339B2 (en) Naphthalene derivative
CN114773340B (en) N-heteroatom multi-ring indolizine and derivative as well as synthesis process and application thereof
CN113429424B (en) Preparation method of [1,2,4] oxadiazino indoline-3-ketone derivative
JPH08208591A (en) 2-aminobenzenesulfonic acid derivative and 2-aminobenzenesulfonyl chloride,derivative their production,and their use as synthetic intermediates
JP2501333B2 (en) Diphenylamine derivative
JP3646223B2 (en) Method for producing aromatic compound by electrophilic reaction and aromatic compound
ES2348770T3 (en) DIRECT SYNTHESIS OF QUATERNARY SALTS.
JP2907475B2 (en) Process for producing (1,2,3-thiadiazol-4-yl) carbaldehyde and intermediate
CN114524790A (en) C2 alkynyl disubstituted 2H-chromene compound and preparation method thereof
JP2706554B2 (en) 4-trifluoromethylaniline derivative and method for producing the same
JP3328694B2 (en) Method for producing nitrogen-containing heterocyclic compound
KR810000293B1 (en) Process for preparing substituted amino quinazoline derivatives
KR880001850B1 (en) Preparation process for derivertives of 5-fluoro pyridone
JPH06228103A (en) New octahydroacridine derivative and its production
JP2005134365A (en) Chiral shift reagent for nmr consisting of optical active binaphthyl compound
JP2812541B2 (en) New ether diamine and method for producing the same

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees